World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country

Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2012, Vol.44 (1), p.47-48
Hauptverfasser: Shah, P.R, Modi, P.R, Kute, V.B, Vanikar, A.V, Patel, H.V, Gumber, M.R, Shah, V.R, Trivedi, H.L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 48
container_issue 1
container_start_page 47
container_title Transplantation proceedings
container_volume 44
creator Shah, P.R
Modi, P.R
Kute, V.B
Vanikar, A.V
Patel, H.V
Gumber, M.R
Shah, V.R
Trivedi, H.L
description Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.
doi_str_mv 10.1016/j.transproceed.2011.11.029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_920366378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0041134511016265</els_id><sourcerecordid>920366378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</originalsourceid><addsrcrecordid>eNqNklGLEzEQxxdRvHr6FSQI4tPWTLKb3b0H4Wg9FSuCd-JjyCWzkrpNesm2UPzyztoeik_CQEjmP_8Mv5mieAF8DhzU6_V8TCbkbYoW0c0FB5hTcNE9KGbQNrIUSsiHxYzzCkqQVX1WPMl5zekuKvm4OBNCAq-belb8_BbT4NhH7wIe2NIcGNnxC_YJnbdmYJd5i3bMLPYMOFv5PZbLGGJiXzBQ-uZ3I4MJoxl9DJn5wAy79uH7gGyBYcTErlLc0OMS9zjELaXYIu7CmA5Pi0e9GTI-O53nxdertzeL9-Xq87sPi8tVaStVjaUDsI0wIGvT1D04bpTgtjV15zrRomrNLdQSmw7QGXSg6kYo47DqpcFeKnlevDr6ErG7HeZRb3y2OFDbGHdZd4JLpWTTkvLiqLQp5pyw19vkNyYdNHA9sddr_Td7PbHXFMSeip-fvtndbih3X3oPmwQvTwKTiW1PRtbnP7q6g65VQLrlUYcEZe8x6Ww9BksjSTQM7aL_v37e_GNjBx-mqf7AA-Z13CUaYdags9BcX0_bMi0LTMZC1fIXgP69Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>920366378</pqid></control><display><type>article</type><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</creator><creatorcontrib>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</creatorcontrib><description>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2011.11.029</identifier><identifier>PMID: 22310575</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Biomarkers - blood ; Creatinine - blood ; Developing Countries ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Global Health ; Graft Rejection - blood ; Graft Rejection - etiology ; Graft Rejection - mortality ; Graft Rejection - prevention &amp; control ; Graft Survival ; Health Promotion ; Histocompatibility ; Histocompatibility Testing ; HLA Antigens - immunology ; Humans ; Immunosuppressive Agents - therapeutic use ; India ; Kidney Failure, Chronic - therapy ; Kidney Transplantation - adverse effects ; Kidney Transplantation - immunology ; Kidney Transplantation - mortality ; Living Donors ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Time Factors ; Tissue, organ and graft immunology ; Treatment Outcome</subject><ispartof>Transplantation proceedings, 2012, Vol.44 (1), p.47-48</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</citedby><cites>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134511016265$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,4010,4036,4037,23909,23910,25118,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25919861$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22310575$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, P.R</creatorcontrib><creatorcontrib>Modi, P.R</creatorcontrib><creatorcontrib>Kute, V.B</creatorcontrib><creatorcontrib>Vanikar, A.V</creatorcontrib><creatorcontrib>Patel, H.V</creatorcontrib><creatorcontrib>Gumber, M.R</creatorcontrib><creatorcontrib>Shah, V.R</creatorcontrib><creatorcontrib>Trivedi, H.L</creatorcontrib><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Creatinine - blood</subject><subject>Developing Countries</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Global Health</subject><subject>Graft Rejection - blood</subject><subject>Graft Rejection - etiology</subject><subject>Graft Rejection - mortality</subject><subject>Graft Rejection - prevention &amp; control</subject><subject>Graft Survival</subject><subject>Health Promotion</subject><subject>Histocompatibility</subject><subject>Histocompatibility Testing</subject><subject>HLA Antigens - immunology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>India</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - mortality</subject><subject>Living Donors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Time Factors</subject><subject>Tissue, organ and graft immunology</subject><subject>Treatment Outcome</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNklGLEzEQxxdRvHr6FSQI4tPWTLKb3b0H4Wg9FSuCd-JjyCWzkrpNesm2UPzyztoeik_CQEjmP_8Mv5mieAF8DhzU6_V8TCbkbYoW0c0FB5hTcNE9KGbQNrIUSsiHxYzzCkqQVX1WPMl5zekuKvm4OBNCAq-belb8_BbT4NhH7wIe2NIcGNnxC_YJnbdmYJd5i3bMLPYMOFv5PZbLGGJiXzBQ-uZ3I4MJoxl9DJn5wAy79uH7gGyBYcTErlLc0OMS9zjELaXYIu7CmA5Pi0e9GTI-O53nxdertzeL9-Xq87sPi8tVaStVjaUDsI0wIGvT1D04bpTgtjV15zrRomrNLdQSmw7QGXSg6kYo47DqpcFeKnlevDr6ErG7HeZRb3y2OFDbGHdZd4JLpWTTkvLiqLQp5pyw19vkNyYdNHA9sddr_Td7PbHXFMSeip-fvtndbih3X3oPmwQvTwKTiW1PRtbnP7q6g65VQLrlUYcEZe8x6Ww9BksjSTQM7aL_v37e_GNjBx-mqf7AA-Z13CUaYdags9BcX0_bMi0LTMZC1fIXgP69Rg</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Shah, P.R</creator><creator>Modi, P.R</creator><creator>Kute, V.B</creator><creator>Vanikar, A.V</creator><creator>Patel, H.V</creator><creator>Gumber, M.R</creator><creator>Shah, V.R</creator><creator>Trivedi, H.L</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><author>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Creatinine - blood</topic><topic>Developing Countries</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Global Health</topic><topic>Graft Rejection - blood</topic><topic>Graft Rejection - etiology</topic><topic>Graft Rejection - mortality</topic><topic>Graft Rejection - prevention &amp; control</topic><topic>Graft Survival</topic><topic>Health Promotion</topic><topic>Histocompatibility</topic><topic>Histocompatibility Testing</topic><topic>HLA Antigens - immunology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>India</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - mortality</topic><topic>Living Donors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Time Factors</topic><topic>Tissue, organ and graft immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, P.R</creatorcontrib><creatorcontrib>Modi, P.R</creatorcontrib><creatorcontrib>Kute, V.B</creatorcontrib><creatorcontrib>Vanikar, A.V</creatorcontrib><creatorcontrib>Patel, H.V</creatorcontrib><creatorcontrib>Gumber, M.R</creatorcontrib><creatorcontrib>Shah, V.R</creatorcontrib><creatorcontrib>Trivedi, H.L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, P.R</au><au>Modi, P.R</au><au>Kute, V.B</au><au>Vanikar, A.V</au><au>Patel, H.V</au><au>Gumber, M.R</au><au>Shah, V.R</au><au>Trivedi, H.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2012</date><risdate>2012</risdate><volume>44</volume><issue>1</issue><spage>47</spage><epage>48</epage><pages>47-48</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>22310575</pmid><doi>10.1016/j.transproceed.2011.11.029</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2012, Vol.44 (1), p.47-48
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_920366378
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biological and medical sciences
Biomarkers - blood
Creatinine - blood
Developing Countries
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Global Health
Graft Rejection - blood
Graft Rejection - etiology
Graft Rejection - mortality
Graft Rejection - prevention & control
Graft Survival
Health Promotion
Histocompatibility
Histocompatibility Testing
HLA Antigens - immunology
Humans
Immunosuppressive Agents - therapeutic use
India
Kidney Failure, Chronic - therapy
Kidney Transplantation - adverse effects
Kidney Transplantation - immunology
Kidney Transplantation - mortality
Living Donors
Male
Medical sciences
Middle Aged
Miscellaneous
Public health. Hygiene
Public health. Hygiene-occupational medicine
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Time Factors
Tissue, organ and graft immunology
Treatment Outcome
title World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A06%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=World%20Kidney%20Day%202010:%20Medical%20Aspects%20of%2010%20Live-Donor%20Renal%20Transplantations%20in%20a%20Single%20Center%20From%20a%20Developing%20Country&rft.jtitle=Transplantation%20proceedings&rft.au=Shah,%20P.R&rft.date=2012&rft.volume=44&rft.issue=1&rft.spage=47&rft.epage=48&rft.pages=47-48&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2011.11.029&rft_dat=%3Cproquest_cross%3E920366378%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=920366378&rft_id=info:pmid/22310575&rft_els_id=1_s2_0_S0041134511016265&rfr_iscdi=true